Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience.

MLA

Hleyhel, Mira, et al. “Risk of Cancer in Children Exposed to Antiretroviral Nucleoside Analogues in Utero: The French Experience.” Environmental and Molecular Mutagenesis, vol. 60, no. 5, June 2019, pp. 404–09. EBSCOhost, https://doi.org/10.1002/em.22162.

APA

Hleyhel, M., Goujon, S., Sibiude, J., Tubiana, R., Dollfus, C., Faye, A., Mandelbrot, L., Clavel, J., Warszawski, J., & Blanche, S. (2019). Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience. Environmental and Molecular Mutagenesis, 60(5), 404–409. https://doi.org/10.1002/em.22162

Chicago

Hleyhel, Mira, Stéphanie Goujon, Jeanne Sibiude, Roland Tubiana, Catherine Dollfus, Albert Faye, Laurent Mandelbrot, Jacqueline Clavel, Josiane Warszawski, and Stéphane Blanche. 2019. “Risk of Cancer in Children Exposed to Antiretroviral Nucleoside Analogues in Utero: The French Experience.” Environmental and Molecular Mutagenesis 60 (5): 404–9. doi:10.1002/em.22162.